{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T00:18:24Z","timestamp":1793837904026,"version":"4.6.1"},"reference-count":49,"publisher":"Bentham Science Publishers Ltd.","issue":"4","funder":[{"DOI":"10.13039\/501100011447","name":"Science and Technology Research of Henan Provincial Department of Education","doi-asserted-by":"publisher","award":["14A350003"],"award-info":[{"award-number":["14A350003"]}],"id":[{"id":"10.13039\/501100011447","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011447","name":"Science and Technology Research of Henan Provincial Department of Education","doi-asserted-by":"publisher","award":["14B350012"],"award-info":[{"award-number":["14B350012"]}],"id":[{"id":"10.13039\/501100011447","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011447","name":"Science and Technology Research of Henan Provincial Department of Education","doi-asserted-by":"publisher","award":["13A350092"],"award-info":[{"award-number":["13A350092"]}],"id":[{"id":"10.13039\/501100011447","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011447","name":"Science and Technology Development Project of Henan Province","doi-asserted-by":"publisher","award":["152102310077"],"award-info":[{"award-number":["152102310077"]}],"id":[{"id":"10.13039\/501100011447","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"publisher","award":["U1304826"],"award-info":[{"award-number":["U1304826"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CCDT"],"published-print":{"date-parts":[[2019,3,21]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p> Improving poorly soluble drugs into druggability was a major problem faced\nby pharmaceutists. Nanosuspension can improve the druggability of insoluble drugs by improving the\nsolubility, chemical stability and reducing the use of additives, which provided a new approach for the\ndevelopment and application of the insoluble drugs formulation. Paclitaxel (PTX) is a well-known BCS\nclass IV drug with poor solubility and permeability. Also, many studies have proved that paclitaxel is a\nsubstrate of the membrane-bound drug efflux pump P-glycoprotein (P-gp), therefore it often shows\nlimited efficacy against the resistant tumors and oral absorption or uptake.\n<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p> To manufacture an enhanced-penetration PTX nanosuspension (PTX-Nanos), and evaluate\nthe physicochemical property, pharmacokinetics and tissue distribution in vivo and cytotoxic effect\nin vitro.\n<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p> PTX-Nanos were prepared by microprecipitation-high pressure homogenization, with a\ngood biocompatibility amphiphilic block copolymer poly(L-phenylalanine)-b-poly(L-aspartic acid)\n(PPA-PAA) as stabilizer.\n<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p> The PTX-Nanos had a sustained-dissolution manner and could effectively reduce plasma peak\nconcentration and extend plasma circulating time as compared to PTX injection, markedly passively\ntargeting the MPS-related organs, such as liver and spleen. This unique property might enhance treatment\nof cancer in these tissues and reduce the side effects in other normal tissues. Moreover, the hybrid\nstabilizers could enhance penetration of PTX in PTX-Nanos to multidrug resistance cells.\n<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p> To sum up, our results showed that the optimal formula could improve the solubility of\nPTX and the stability of the product. The PTX-Nanos developed in this research would be a promising\ndelivery platform in cancer treatment.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1568009618666180629150927","type":"journal-article","created":{"date-parts":[[2018,6,29]],"date-time":"2018-06-29T07:39:49Z","timestamp":1530257989000},"page":"338-347","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Formulation, Pharmacokinetic Evaluation and Cytotoxicity of an Enhanced- penetration Paclitaxel Nanosuspension"],"prefix":"10.2174","volume":"19","author":[{"given":"Yanping","family":"Cao","sequence":"first","affiliation":[{"name":"Institute of Materia Medica, School of Pharmacy, Henan University, Jinming Road, Kaifeng, 475004, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihao","family":"Wei","sequence":"additional","affiliation":[{"name":"Institute of Materia Medica, School of Pharmacy, Henan University, Jinming Road, Kaifeng, 475004, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Li","sequence":"additional","affiliation":[{"name":"Institute of Materia Medica, School of Pharmacy, Henan University, Jinming Road, Kaifeng, 475004, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Wang","sequence":"additional","affiliation":[{"name":"Institute of Materia Medica, School of Pharmacy, Henan University, Jinming Road, Kaifeng, 475004, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yin","sequence":"additional","affiliation":[{"name":"Institute of Materia Medica, School of Pharmacy, Henan University, Jinming Road, Kaifeng, 475004, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongxiao","family":"Chen","sequence":"additional","affiliation":[{"name":"Institute of Materia Medica, School of Pharmacy, Henan University, Jinming Road, Kaifeng, 475004, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfei","family":"Wang","sequence":"additional","affiliation":[{"name":"Institute of Materia Medica, School of Pharmacy, Henan University, Jinming Road, Kaifeng, 475004, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongchao","family":"Chen","sequence":"additional","affiliation":[{"name":"Institute of Materia Medica, School of Pharmacy, Henan University, Jinming Road, Kaifeng, 475004, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Yuan","sequence":"additional","affiliation":[{"name":"Institute of Materia Medica, School of Pharmacy, Henan University, Jinming Road, Kaifeng, 475004, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Pu","sequence":"additional","affiliation":[{"name":"Institute of Materia Medica, School of Pharmacy, Henan University, Jinming Road, Kaifeng, 475004, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanlan","family":"Zong","sequence":"additional","affiliation":[{"name":"Institute of Materia Medica, School of Pharmacy, Henan University, Jinming Road, Kaifeng, 475004, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaofeng","family":"Duan","sequence":"additional","affiliation":[{"name":"Institute of Materia Medica, School of Pharmacy, Henan University, Jinming Road, Kaifeng, 475004, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.carbpol.2014.05.021","volume":"111","author":"Yang R.","year":"2014","unstructured":"Yang R, Chen JB, Xiao CF, Liu ZC, Gao ZY, Yan SJ, Zhang JH, Zhang HB, Lin J.  Inclusion complex of GA-13316 with \u03b2-cyclodextrin: preparation, characterization, molecular modeling, and  evaluation.","journal-title":"Carbohydr Polym"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.colsurfb.2017.10.032","volume":"161","author":"Efiana N.A.","year":"2017","unstructured":"Efiana NA, Phan TNQ, Wicaksono AJ, Bernkop-Schnurch A.  Mucus permeating self-emulsifying drug delivery systems (SEDDS): About the impact of mucolytic enzymes.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2174\/1389201016666150118135107","volume":"16","author":"Chaudhury A.","year":"2015","unstructured":"Chaudhury A, Das S.  Folate receptor targeted liposomes encapsulating anti-cancer drugs.","journal-title":"Curr Pharm Biotechnol"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1021\/bm501290t","volume":"15","author":"Deng H.","year":"2014","unstructured":"Deng H, Liu J, Zhao X, Zhang Y, Liu J, Xu S, Deng L, Dong A, Zhang J.  PEG-b-PCL copolymer micelles with the ability of pH-controlled negative-to-positive charge reversal for intracellular delivery of doxorubicin.","journal-title":"Biomacromolecules"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.colsurfb.2016.11.024","volume":"150","author":"Zhang T.","year":"2016","unstructured":"Zhang T, Luo J, Fu Y, Li H, Ding R, Gong T, Zhang Z.  Novel oral administrated paclitaxel micelles with enhanced bioavailability and antitumor efficacy for resistant breast cancer.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/chromsci\/bmx036","volume":"55","author":"Dousa M.","year":"2017","unstructured":"Dousa M, Meca L, Gibala P, Jirman J, Tkadlecova M, Srbek J, Salandova J, Kovalcikova E, Brichac J.  Esterification of ibuprofen in soft gelatin capsules formulations-identification, synthesis and liquid chromatography separation of the degradation products.","journal-title":"J Chromatogr Sci"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1002\/jps.22405","volume":"100","author":"Stephenson G.A.","year":"2011","unstructured":"Stephenson GA, Aburub A, Woods TA.  Physical stability of salts of weak bases in the solid-state.","journal-title":"J Pharm Sci"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1021\/cg900129f","volume":"9","author":"Schultheiss N.","year":"2009","unstructured":"Schultheiss N, Newman A.  Pharmaceutical cocrystals and their physicochemical properties.","journal-title":"Cryst Growth Des"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.addr.2007.05.010","volume":"59","author":"Serajuddin A.T.M.","year":"2007","unstructured":"Serajuddin ATM.  Salt formation to improve drug solubility.","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ijpharm.2017.10.040","volume":"535","author":"Zhao B.","year":"2017","unstructured":"Zhao B, Gu S, Du Y, Shen M, Liu X, Shen Y.  Solid lipid nanoparticles as carriers for oral delivery of hydroxysafflor yellow A.","journal-title":"Int J Pharm"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1039\/C2AN36364J","volume":"138","author":"Edwards F.","year":"2013","unstructured":"Edwards F, Tsakmaka C, Mohr S, Fielden PR, Goddard NJ, Booth J, Tam KY.  Using droplet-based microfluidic technology to study the precipitation of a poorly water-soluble weakly basic drug upon a pH-shift.","journal-title":"The Analyst"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2174\/157341309789378177","volume":"5","author":"Pu X.H.","year":"2009","unstructured":"Pu XH, Sun J, Li M, He ZG.  Formulation of nanosuspensions as a new approach for the delivery of poorly soluble drugs.","journal-title":"Curr Nanosci"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"5858","DOI":"10.1021\/jm0706416","volume":"50","author":"Bergstrom C.A.","year":"2007","unstructured":"Bergstrom CA, Wassvik CM, Johansson K, Hubatsch I.  Poorly soluble marketed drugs display solvation limited solubility.","journal-title":"J Med Chem"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.2147\/DDDT.S114962","volume":"10","author":"Shah S.M.","year":"2016","unstructured":"Shah SM, Ullah F, Khan S, Shah SM, de Matas M, Hussain Z, Minhas MU.  AbdEl-Salam, N.M.; Assi, K.H.; Isreb, M. Smart nanocrystals of artemether: fabrication, characterization, and comparative  and  antimalarial evaluation.","journal-title":"Drug Des Devel Ther"},{"key":"ref=15","first-page":"1","author":"Liu C.Z.","year":"2016","unstructured":"Liu CZ, Chang JH, Zhang L, Xue HF, Liu XG, Liu P, Fu Q.  Preparation and evaluation of diosgenin nanocrystals to improve oral bioavailability.","journal-title":"AAPS PharmSciTech"},{"key":"ref=16","first-page":"1","author":"Kassem M.A.","year":"2016","unstructured":"Kassem MA, ElMeshad AN, Fares AR.  Enhanced solubility and dissolution rate of lacidipine nanosuspension: formulation  antisolvent sonoprecipitation technique and optimization using box-behnken design.","journal-title":"AAPS PharmSciTech"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/nrd1494","volume":"3","author":"Rabinow B.E.","year":"2004","unstructured":"Rabinow BE.  Nanosuspensions in drug delivery.","journal-title":"Nat Rev Drug Discov"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ijpharm.2009.05.062","volume":"379","author":"Pu X.","year":"2009","unstructured":"Pu X, Sun J, Wang Y, Wang Y, Liu X, Zhang P, Tang X, Pan W, Han J, He Z.  Development of a chemically stable 10-hydroxycamptothecin nanosuspensions.","journal-title":"Int J Pharm"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.ejpb.2004.03.022","volume":"58","author":"Moschwitzer J.","year":"2004","unstructured":"Moschwitzer J, Achleitner G, Pomper H, Muller RH.  Development of an intravenously injectable chemically stable aqueous omeprazole formulation using nanosuspension technology.","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ijpharm.2010.11.009","volume":"404","author":"Gao L.","year":"2011","unstructured":"Gao L, Liu G, Wang X, Liu F, Xu Y, Ma J.  Preparation of a chemically stable quercetin formulation using nanosuspension technology.","journal-title":"Int J Pharm"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.nano.2016.11.004","volume":"13","author":"Bi C.","year":"2017","unstructured":"Bi C, Miao XQ, Chow SF, Wu WJ, Yan R, Liao YH, Chow AH, Zheng Y.  Particle size effect of curcumin nanosuspensions on cytotoxicity, cellular internalization,  pharmacokinetics and biodistribution.","journal-title":"Nanotechnol Biol Med"},{"key":"ref=22"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2174\/157341308783591807","volume":"4","author":"Kumar M.P.","year":"2008","unstructured":"Kumar MP, Rao YM, Apte S.  Formulation of nanosuspensions of albendazole for oral administration.","journal-title":"Curr Nanosci"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/jac\/45.1.77","volume":"45","author":"Peters K.","year":"2000","unstructured":"Peters K, Leitzke S, Diederichs JE, Borner K, Hahn H, Muller RH, Ehlers S.  Preparation of a clofazimine nanosuspension for intravenous use and evaluation of its therapeutic efficacy in murine Mycobacterium avium infection.","journal-title":"J Antimicrob Chemother"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"762","DOI":"10.2174\/157341312802884553","volume":"8","author":"Pu X.H.","year":"2012","unstructured":"Pu XH, Sun J, Qin YM, Zhang X, Zhang P, Yan ZT, He ZG.  The passive targeting and the cytotoxicity of intravenous 10-HCPT nanosuspension.","journal-title":"Curr Nanosci"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0022-0248(88)90294-1","volume":"90","author":"Boistelle R.","year":"1988","unstructured":"Boistelle R, Astier JP.  Crystallization mechanisms in solution.","journal-title":"J Cryst Growth"},{"key":"ref=27","first-page":"122","volume":"70","author":"Florence A.T.","year":"1998","unstructured":"Florence AT, Attwood D.  Physicochemical principles of pharmacy.","journal-title":"Am J Pharm Educ"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ijpharm.2011.03.050","volume":"411","author":"Liu P.","year":"2011","unstructured":"Liu P, Rong X, Laru J, van Veen B, Kiesvaara J, Hirvonen J, Laaksonen T, Peltonen L.  Nanosuspensions of poorly soluble drugs: preparation and development by wet milling.","journal-title":"Int J Pharm"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.addr.2010.12.007","volume":"63","author":"Merisko-Liversidge E.","year":"2011","unstructured":"Merisko-Liversidge E, Liversidge GG.  Nanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technology.","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ijpharm.2016.10.029","volume":"515","author":"Zhao D.","year":"2016","unstructured":"Zhao D, Zhang H, Yang S, He W, Luan Y.  Redox-sensitive mPEG-SS-PTX\/TPGS mixed micelles: An efficient drug delivery system for overcoming multidrug resistance.","journal-title":"Int J Pharm"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.colsurfb.2013.06.004","volume":"111","author":"Gao L.","year":"2013","unstructured":"Gao L, Liu G, Kang J, Niu M, Wang Z, Wang H, Ma J, Wang X.  Paclitaxel nanosuspensions coated with P-gp inhibitory surfactants: I. Acute toxicity and pharmacokinetics studies.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1200\/JCO.2000.18.12.2468","volume":"18","author":"Malingre M.M.","year":"2000","unstructured":"Malingre MM, Terwogt JM, Beijnen JH, Rosing H, Koopman FJ, van Tellingen O, Duchin K, Huinink WW, Swart M, Lieverst J, Schellens JH.  Phase I and pharmacokinetic study of oral paclitaxel.","journal-title":"J Clin Oncol"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3109\/07357909509031919","volume":"13","author":"Huizing M.T.","year":"1995","unstructured":"Huizing MT, Misser VHS, Pieters RC, ten Bokkel Huinink WW, Veenhof CHN, Vermorken JB, Pinedo HM, Beijnen JH.  Taxanes: A new class of antitumor agents.","journal-title":"Cancer Invest"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ejps.2004.12.010","volume":"24","author":"Lee J.","year":"2005","unstructured":"Lee J, Lee SJ, Choi JY, Yoo JY, Ahn CH.  Amphiphilic amino acid copolymers as stabilizers for the preparation of nanocrystal dispersion.","journal-title":"Eur J Pharm Sci"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.colsurfb.2016.05.012","volume":"145","author":"Hong J.","year":"2016","unstructured":"Hong J, Li Y, Xiao Y, Li Y, Guo Y, Kuang H, Wang X.  Annonaceous acetogenins (ACGs) nanosuspensions based on a self-assembly stabilizer and the significantly improved anti-tumor efficacy.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.jconrel.2013.08.006","volume":"172","author":"Wang Y.","year":"2013","unstructured":"Wang Y, Zheng Y, Zhang L, Wang Q, Zhang D.  Stability of nanosuspensions in drug delivery.","journal-title":"J Control Release"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ijpharm.2011.02.051","volume":"409","author":"Ghosh I.","year":"2011","unstructured":"Ghosh I, Bose S, Vippagunta R, Harmon F.  Nanosuspension for improving the bioavailability of a poorly soluble drug and screening of stabilizing agents to inhibit crystal growth.","journal-title":"Int J Pharm"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.3109\/03639045.2015.1115870","volume":"42","author":"Lauro M.R.","year":"2016","unstructured":"Lauro MR, Carbone C, Sansone F, Ruozi B, Chillemi R, Sciuto S, Aquino RP, Puglisi G.  Innovative oral spray-dried Idebenone systems to improve patient compliance.","journal-title":"Drug Development and Industrial Pharmacy,"},{"key":"ref=39","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3109\/10717544.2010.509367","volume":"18","author":"Kumar G.","year":"2011","unstructured":"Kumar G, Sharma S, Shafiq N, Pandhi P, Khuller GK, Malhotra S.  Pharmacokinetics and tissue distribution studies of orally administered nanoparticles encapsulated ethionamide used as potential drug delivery system in management of multi-drug resistant tuberculosis.","journal-title":"Drug Deliv"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.ejps.2012.08.011","volume":"47","author":"Ghosh I.","year":"2012","unstructured":"Ghosh I, Schenck D, Bose S, Ruegger C.  Optimization of formulation and process parameters for the production of nanosuspension by wet media milling technique: Effect of Vitamin E TPGS and nanocrystal particle size on oral absorption.","journal-title":"Eur J Pharm Sci"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.biomaterials.2015.10.019","volume":"75","author":"Mirshafiee V.","year":"2016","unstructured":"Mirshafiee V, Kim R, Park S, Mahmoudi M, Kraft ML.  Impact of protein pre-coating on the protein corona composition and nanoparticle cellular uptake.","journal-title":"Biomaterials"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s13346-016-0320-0","volume":"7","author":"Kari O.K.","year":"2016","unstructured":"Kari OK, Rojalin T, Salmaso S, Barattin M, Jarva H, Meri S, Yliperttula M, Viitala T, Urtti A.  Multi-parametric surface plasmon resonance platform for studying liposome-serum interactions and protein corona formation.","journal-title":"Drug Deliv Transl Res"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"10764","DOI":"10.1021\/acs.langmuir.5b02158","volume":"31","author":"Caracciolo G.","year":"2015","unstructured":"Caracciolo G, Palchetti S, Colapicchioni V, Digiacomo L, Pozzi D, Capriotti AL, La Barbera G, Lagana A.  Stealth effect of biomolecular corona on nanoparticle uptake by immune cells.","journal-title":"Langmuir"},{"key":"ref=44","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1080\/10611860600888850","volume":"14","author":"Manjunath K.","year":"2006","unstructured":"Manjunath K, Venkateswarlu V.  Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration.","journal-title":"J Drug Target"},{"key":"ref=45","first-page":"1497","volume":"6","author":"Wang Y.","year":"2011","unstructured":"Wang Y, Li X, Wang L, Xu Y, Cheng X, Wei P.  Formulation and pharmacokinetic evaluation of a paclitaxel nanosuspension for intravenous delivery.","journal-title":"Int J Nanomed"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.3109\/03639045.2014.950272","volume":"41","author":"Wei L.","year":"2015","unstructured":"Wei L, Ji Y, Gong W, Kang Z, Meng M, Zheng A, Zhang X, Sun J.  Preparation, physical characterization and pharmacokinetic study of paclitaxel nanocrystals.","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=47","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ejps.2015.12.019","volume":"83","author":"Yin T.","year":"2016","unstructured":"Yin T, Cai H, Liu J, Cui B, Wang L, Yin L, Zhou J, Huo M.  Biological evaluation of PEG modified nanosuspensions based on human serum albumin for tumor targeted delivery of paclitaxel.","journal-title":"Eur J Pharm Sci"},{"key":"ref=48","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jconrel.2016.07.015","volume":"237","author":"Gao W.","year":"2016","unstructured":"Gao W, Chen Y, Thompson DH, Park K, Li T.  Impact of surfactant treatment of paclitaxel nanocrystals on biodistribution and tumor accumulation in tumor-bearing mice.","journal-title":"J Control Release"},{"key":"ref=49","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1208\/s12248-015-9774-0","volume":"17","author":"Chen Y.","year":"2015","unstructured":"Chen Y, Li T.  Cellular uptake mechanism of paclitaxel nanocrystals determined by confocal imaging and kinetic measurement.","journal-title":"AAPS J"}],"container-title":["Current Cancer Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/163360","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,22]],"date-time":"2019-09-22T10:38:38Z","timestamp":1569148718000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/163360\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,21]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,3,21]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1568009618666180629150927","relation":{},"ISSN":["1568-0096"],"issn-type":[{"value":"1568-0096","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3,21]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2017-12-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-02-06","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-06-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-03-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}